Home / Recalls / IntegraDose Compounding Services LLC / D-0593-2026

D-0593-2026 Class II Ongoing

Recalled by IntegraDose Compounding Services LLC — Shoreview, MN

Recall Details

Product Type
Drugs
Report Date
June 24, 2026
Initiation Date
May 18, 2026
Termination Date
N/A
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
287 units

Product Description

Vasopressin 2 Units/2 mL in 0.9% Sodium Chloride, syringe, IntegraDose Compounding Services, LLC. 3650 Victoria St N, Suite 900, Shoreview, MN, NDC 71139-0190-1.

Reason for Recall

Subpotent Drug

Distribution Pattern

U.S.A. Nationwide

Code Information

Lot#: 20260327VAS-3, BUD: 05/26/2026; 20260320VAS-3, BUD: 05/19/2026.

Other recalls by IntegraDose Compounding Services LLC

  • D-0548-2026 Class II — fentaNYL Citrate, Sterile CADD for Injection, 2,2500 mcg/50mL in Sterile Water, (May 12, 2026)
  • D-0015-2026 Class I — Oxytocin 30 Units/500 mL in 0.9% Sodium Chloride for intravenous use, Rx only, I (September 16, 2025)
  • D-0432-2024 Class II — fentaNYL Citrate 2,500 mcg/50mL in Sterile Water, 50 mL CADD for Injection, Inte (March 22, 2024)
  • D-0325-2024 Class II — Vasopressin 2 Units/2 mL in 0.9% Sodium Chloride Sterile Syringe for Injection, (January 22, 2024)
  • D-0258-2024 Class II — Vasopressin 2 Unit/2 mL in 0.9% Sodium Chloride, 2 mL per syringe, Rx Only, 719 (January 12, 2024)
  • D-0896-2021 Class II — ceFAZolin, 2 G/20 mL in Sterile Water, 20 mL Sterile Syringe for Injection, Inte (September 17, 2021)
  • D-0897-2021 Class II — ceFAZolin 3 G in 0.9% Sodium Chloride, 115 mL Bag for Injection, Sterile Product (September 17, 2021)